Follow
Oscar Zaragoza
Oscar Zaragoza
Verified email at isciii.es
Title
Cited by
Cited by
Year
The capsule of the fungal pathogen Cryptococcus neoformans
O Zaragoza, ML Rodrigues, M De Jesus, S Frases, E Dadachova, ...
Advances in applied microbiology 68, 133-216, 2009
5542009
Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport
ML Rodrigues, L Nimrichter, DL Oliveira, S Frases, K Miranda, ...
Eukaryotic cell 6 (1), 48-59, 2007
5092007
Fungal cell gigantism during mammalian infection
O Zaragoza, R García-Rodas, JD Nosanchuk, M Cuenca-Estrella, ...
PLoS pathogens 6 (6), e1000945, 2010
3612010
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
AC Mesa-Arango, L Scorzoni, O Zaragoza
Frontiers in microbiology 3, 286, 2012
3412012
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain
M Puig-Asensio, B Padilla, J Garnacho-Montero, O Zaragoza, JM Aguado, ...
Clinical Microbiology and Infection 20 (4), O245-O254, 2014
3112014
Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival
O Zaragoza, CJ Chrisman, MV Castelli, S Frases, M Cuenca‐Estrella, ...
Cellular microbiology 10 (10), 2043-2057, 2008
3062008
Experimental modulation of capsule size in Cryptococcus neoformans
O Zaragoza, A Casadevall
Biological procedures online 6, 10-15, 2004
2512004
Protective role of trehalose during severe oxidative stress caused by hydrogen peroxide and the adaptive oxidative stress response in Candida albicans
FJ Alvarez-Peral, O Zaragoza, Y Pedreno, JC Argüelles
Microbiology 148 (8), 2599-2606, 2002
2302002
Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO2
O Zaragoza, BC Fries, A Casadevall
Infection and immunity 71 (11), 6155-6164, 2003
2112003
The production of reactive oxygen species is a universal action mechanism of amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug
AC Mesa-Arango, N Trevijano-Contador, E Román, R Sánchez-Fresneda, ...
Antimicrobial agents and chemotherapy 58 (11), 6627-6638, 2014
2102014
Titan cells in Cryptococcus neoformans: cells with a giant impact
O Zaragoza, K Nielsen
Current opinion in microbiology 16 (4), 409-413, 2013
1962013
Basic principles of the virulence of Cryptococcus
O Zaragoza
Virulence 10 (1), 490-501, 2019
1852019
More is not necessarily better: prozone-like effects in passive immunization with IgG
CP Taborda, J Rivera, O Zaragoza, A Casadevall
The Journal of Immunology 170 (7), 3621-3630, 2003
1752003
Disruption of the Candida albicans TPS1Gene Encoding Trehalose-6-Phosphate Synthase Impairs Formation of Hyphae and Decreases Infectivity
O Zaragoza, MA Blazquez, C Gancedo
Journal of bacteriology 180 (15), 3809-3815, 1998
1591998
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile
L Scorzoni, MP de Lucas, AC Mesa-Arango, AM Fusco-Almeida, ...
PloS one 8 (3), e60047, 2013
1582013
The efficacy of complement‐mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves …
O Zaragoza, CP Taborda, A Casadevall
European journal of immunology 33 (7), 1957-1967, 2003
1572003
Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011
J Guinea, Ó Zaragoza, P Escribano, E Martín-Mazuelos, J Pemán, ...
Antimicrobial agents and chemotherapy 58 (3), 1529-1537, 2014
1502014
Amphotericin B mediates killing in Cryptococcus neoformans through the induction of a strong oxidative burst
F Sangalli-Leite, L Scorzoni, AC Mesa-Arango, C Casas, E Herrero, ...
Microbes and infection 13 (5), 457-467, 2011
1352011
Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection
R García-Rodas, A Casadevall, JL Rodríguez-Tudela, M Cuenca-Estrella, ...
PloS one 6 (9), e24485, 2011
1342011
Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications
A Forastiero, AC Mesa-Arango, A Alastruey-Izquierdo, L Alcazar-Fuoli, ...
Antimicrobial Agents and Chemotherapy 57 (10), 4769-4781, 2013
1332013
The system can't perform the operation now. Try again later.
Articles 1–20